InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Valantine Hannah, Director. Officer active across 2 companies, notably CareDx, Inc.. Aggregated, 7 disclosures have been recorded. Total volume traded: €44k. The latest transaction was disclosed on 16 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
04,863 shares0
Common Stock
SEC:0001217234-22-000123:0·
€22,1851,764 shares@ €12.57650.0001% mcap100.0% of flow
Common Stock
SEC:0000899243-22-000180·
Ideal exit: 25 Sept 2022 (T+270)
€22,1851,764 shares@ €12.57650.0001% mcap50.0% of flow
Common Stock
SEC:0000899243-22-000180:0·
Ideal exit: 25 Sept 2022 (T+270)
0131 shares0
Common Stock
SEC:0001217234-21-000221·
0131 shares0
Common Stock
SEC:0001217234-21-000221:0·
01,630 shares0
Common Stock
SEC:0001217234-21-000160·
01,630 shares0
Common Stock
SEC:0001217234-21-000160:0·
7 of 7 declarations
About Valantine Hannah
Hannah Valantine is a Director at CareDx, Inc. and BridgeBio Pharma, Inc. In these roles, she participates in the governance of the companies and strategic decision-making. Valantine brings her expertise and industry knowledge, which is essential for guiding growth and innovation initiatives. Her commitment to operational excellence is beneficial for both companies.
